honokiol

Honokiol is a lignan isolated from the bark, seed cones, and leaves of trees belonging to the genus ''Magnolia''. It has been identified as one of the chemical compounds in some traditional eastern herbal medicines along with magnolol, 4-O-methylhonokiol, and obovatol.

Biology

Honokiol has been extracted from a number of species of ''Magnolia'' native to many regions of the globe. ''Magnolia grandiflora'', which is native to the American South, as well as Mexican species like '' Magnolia dealbata'' have been found to be sources of honokiol. Traditionally in Asian medicine, the '' Magnolia biondii'', ''Magnolia obovata'', and ''Magnolia officinalis'' are commonly used. The compound itself has a spicy odor.

Because of its physical properties, honokiol can readily cross the blood brain barrier and the blood-cerebrospinal fluid barrier. As a result, honokiol is a potentially potent therapy with high bioavailability.

Chemistry

Structure

Honokiol belongs to a class of neolignan biphenols. As a polyphenol it is relatively small and can interact with cell membrane proteins through intermolecular interactions like hydrogen bonding, hydrophobic interactions, or aromatic pi orbital co-valency. It is hydrophobic and readily dissolved in lipids. It is structurally similar to propofol.

Purification

There are several methods for purifying and isolating honokiol. In nature, honokiol exists with its structural isomer magnolol, which differs from honokiol only by the position of one hydroxyl group. Because of the very similar properties of magnolol and honokiol, purification has often been limited to a HPLC or electromigration. However, methods developed in 2006 by workers in the lab of Jack L. Arbiser, took advantage of the proximity of the phenolic hydroxyl groups in magnolol, which form a protectable diol, to generate a magnolol acetonide (Figure 1), with a subsequent simple purification via flash chromatography over silica.

Figure 1

Additionally a rapid separation approach was published in the ''Journal of Chromatography A'' in 2007. The process uses high-capacity high-speed countercurrent chromatography (high-capacity HSCCC). Through this method honokiol can be separated and purified to above 98% purity with a high yield in under an hour.

History

Traditional medicine

Extracts from the bark or seed cones of the ''Magnolia'' tree have been widely used in traditional medicine in China, Korea, and Japan.

Magnolia bark has traditionally been used in Eastern medicine as analgesic and to treat anxiety and mood disorders. In traditional Chinese medicine, magnolia bark is called ''Houpu'' and is most commonly taken from two species, ''Magnolia obovata'' and ''Magnolia officinalis''. Some Chinese traditional formulas containing Houpu include Banxia Houpu Tang (半夏厚朴丸), Xiao Zhengai Tang, Ping Wei San(平胃散) and Shenmi Tang. Japanese Kampo formulas include, Hange-koboku-to (半夏厚朴湯) and Sai-boku-to (柴朴湯).

Western medical research

Honokiol is a pleiotropic compound, meaning it is able to act on the body through a number of pathways. This diversity of interaction makes it a viable therapy for a number of conditions in the central nervous system, cardiovascular system, and gastrointestinal system. It has been shown to have antitumorigenic, anti-inflammatory, and antioxidant effects as well.

Side effects and contraindications

Research has shown a limited side effect profile for honokiol, and it appears to be well tolerated. However, its antithrombotic effects could cause hemorrhage especially in patients with conditions that would put them at a higher risk like hemophilia or Von Willebrand disease. Additionally, patients already taking anticoagulants should talk to their doctor before taking honokiol supplements. In a 2002 study, researchers induced cell death in fetal rat cortical neurons by directly applying 100μM ''in vitro''.

Pharmacology

Antitumorigenic activities

Honokiol has shown pro-apoptotic effects in melanoma, sarcoma, myeloma, leukemia, bladder, lung, prostate, oral squamous cell carcinoma, in glioblastome multiforme cells and colon cancer cell lines. Honokiol inhibits phosphorylation of Akt, p44/42 mitogen-activated protein kinase (MAPK), and src. Additionally, honokiol regulates the nuclear factor kappa B (NF-κB) activation pathway, an upstream effector of vascular endothelial growth factor (VEGF), MCL1, and cyclooxygenase 2 (COX-2), all significant pro-angiogenic and survival factors. Honokiol induces caspase-dependent apoptosis in a TRAIL-mediated manner, and potentiates the pro-apoptotic effects of doxorubicin and other etoposides. So potent is honokiol's pro-apoptotic effects that it overcomes even notoriously drug resistant neoplasms such as multiple myeloma and chronic B-cell leukemia. Honokiol also acts on the PI3K/mTOR pathway in tumor cells while maintaining pathway activity in T cells.

Neurotrophic activity

Honokiol has been shown to promote neurite outgrowth and have neuroprotective effects in rat cortical neurons. Additionally, honokiol increases free cytoplasmic reforforason Ca²⁺ in rat cortical neurons. Honokiol is a weak cannabinoid CB2 receptor ligand but the naturally occurring derivative 4-O-methylhonokiol was shown to be a potent and selective cannabinoid CB2 receptor inverse agonist and to possess antiosteoclastic effects.

Antithrombotic activity

Honokiol inhibits platelet aggregation in rabbits in a dose-dependent manner, and protects cultured RAEC against oxidized low density lipoprotein injury. Honokiol significantly increases the prostacyclin metabolite 6-keto-PGF1alpha, potentially the key factor in honokiol's antithrombotic activity.

Anti-inflammatory activity

Studies examining honokiol as a protective therapy against focal cerebral ischemia-reperfusion injury have identified a number of anti-inflammatory pathways. Neutrophil infiltration of injured tissues can cause further damage and issues with healing. In ''in vitro'' studies, honokiol reduced fMLP (N-formyl-methionyl-leucyl-phenylalanine) and PMA ( phorbol-12-myristate-13-acetate) induced neutrophil firm adhesion which is an integral step for infiltration. Honokiol inhibits ROS production in neutrophils. Honokiol also blocks inflammatory factor production in glial cells through the inhibition on NF-κB activation. This mechanism is believed to suppress production of NO, tumor necrosis factor-α (TNF-α), and RANTES/CCL5.

Antioxidant activity

Honokiol has also been proposed as an antioxidant. The compound protects against lipid peroxidation by interfering with ROS production and migration. Accumulation of ROS extracellularly causes macromolecular damage while intracellular accumulation may induce cytokine activation.

Cytotoxicity inhibition

One way that honokiol acts as a neuroprotective is through cellular regulation and subsequent inhibition of cytotoxicity. Two mechanisms used to achieve this inhibition are GABA_A Modulation and Ca²⁺ Inhibition. Cytotoxicity inhibition may be the neuroprotective mechanism of honokiol. Honokiol has also been shown to inhibit repetitive firing by blocking glutamate.

= GABA_A modulation

=

It is believed that honokiol acts on GABA_A receptors similarly to benzodiazepines and Z-drugs. However, honokiol has been shown to achieve anxiolysis with fewer motor or cognitive side effects than GABA_A receptor agonists such as flurazepam and diazepam. It has been shown that honokiol likely has a higher selectivity for different GABA_A receptor subtypes and both magnolol and honokiol showed higher efficacy when acting on receptors containing δ subunits. GABA_A receptors control ligand-gated Cl⁻ channels that can help increase seizure thresholds through the influx of chloride anions.
Honokiol may also affect the synthesis of GABA. In a study where mice received seven daily injections of honokiol, researchers observed a mild increase in hippocampal levels of glutamate decarboxylase (GAD₆₇) an enzyme that catalyzes the synthesis of GABA. However, the increase was within the margin of error for the method used to quantify the protein.

= Ca²⁺ inhibition

=
A high concentration of Ca²⁺ induces excitotoxicity which is believed to be the main mechanism behind movement disorders such as ALS, Parkinson's disease, and convulsive disorders like epilepsy. Honokiol disrupts the interfaces post synaptic density protein ( PSD95) and neuronal nitric oxide synthase ( nNOS). PSD95 and nNOS coupling to the NMDA receptor causes a conformational change responsible for the intracellular influx of Ca²⁺ which could in turn be a pathway for neurotoxicity. Calcium overloading can also cause damage by over-activation of calcium-stimulated enzymes. Honokiol can reduce calcium influx through inhibition of the fMLP, AlF₄⁻, and thapsigargin G-protein pathways.

Antiviral activity

Honokiol has been shown to inhibit hepatitis C virus (HCV) infection in vitro. It has weak in vitro activity against human immunodeficiency virus (HIV-1).

Metabolic activity

Honokiol was shown to normalize blood glucose levels and prevent body weight gain in diabetic mice by acting as agonist of PPARgamma.

Pharmacokinetics

The pharmacokinetics of honokiol have been explored in rats and mice; however, further research must be done in humans. Intravenous delivery of 5–10 mg/kg in rodent models has shown a plasma half-life of around 40–60 minutes while intraperitoneal injections of 250 mg/kg had a plasma half-life around 4–6 hours with maximum plasma concentration occurring between 20–30 minutes.

Delivery methods

Honokiol is most commonly taken orally. There are a number of supplements available containing honokiol. Magnolia tea made from the bark of the tree is also a common delivery method of honokiol. Both Native Americans and Japanese medicine use tea gargles to treat toothaches and sore throats. Because honokiol is highly hydrophobic it must be dissolved in a lipid for many delivery methods. In many current animal studies the compound is dissolved in a lipid emollient and delivered through intraperitoneal injection. There is ongoing work developing liposomal emulsions for IV delivery.

References

External links

Heal Magnolias
''Emory Magazine'', Spring 2004

{{Authority control

Antidepressants
Lignans
Anxiolytics
GABAA receptor positive allosteric modulators
Cannabinoids
Biphenyls
Allyl compounds